Form 4 for PLSE PULSE BIOSCIENCES, INC.
Accepted 2025-09-22 00:00:00 ET · period of report 2025-09-18 · accession 0001437749-25-029646 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-09-22 | 2025-09-18+ | PLSE | Danahy Kevin Patrick | Chief Commercial Off | M - OptEx | $1.53 | +20.4K | 43.7K | +88% | +$31.2K |
| DM | 2025-09-22 | 2025-09-18+ | PLSE | Danahy Kevin Patrick | Chief Commercial Off | S - Sale+OE | $18.49 | -20.4K | 43.3K | -32% | -$377.2K |
| DM | 2025-09-22 | 2025-09-18+ | PLSE | Danahy Kevin Patrick | Chief Commercial Off | M - OptEx | $0.00 | -20.4K | 429.6K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-18 | M | A | 20,000 | $1.53 | 63,298 | D | — | — | |
| 2 | Common | Common Stock | 2025-09-19 | S | D | 400 | $18.48 | 43,298 | D | — | — | |
| 3 | Common | Common Stock | 2025-09-19 | M | A | 400 | $1.53 | 43,698 | D | — | — | |
| 4 | Common | Common Stock | 2025-09-18 | S | D | 20,000 | $18.49 | 43,298 | D | — | — | (F2) The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $18.48 to $19.48 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range. |
| 5 | Derivative | Stock Option (right to buy) | 2025-09-18 | M | D | 20,000 | $0.00 | 430,000 | D | $1.53 · — to 2032-09-23 | 20,000 Common Stock | (F3) Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022. |
| 6 | Derivative | Stock Option (right to buy) | 2025-09-19 | M | D | 400 | $0.00 | 429,600 | D | $1.53 · — to 2032-09-23 | 400 Common Stock | (F3) Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022. |